NWBO vs. GE

Last updated Jun 24, 2026

NWBO (Northwest Biotherapeutics, Inc.) and GE (General Electric Company) are both stocks. NWBO operates in Biotechnology (Healthcare), while GE operates in Specialty Industrial Machinery (Industrials). Over the past 10 years, NWBO returned -11.32%/yr vs 10.78%/yr for GE. At a 0.04 correlation, their price movements are largely independent.

Performance

NWBO vs. GE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Northwest Biotherapeutics, Inc. (NWBO) and General Electric Company (GE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NWBO achieves a -16.85% return, which is significantly lower than GE's 15.89% return. Over the past 10 years, NWBO has underperformed GE with an annualized return of -11.32%, while GE has yielded a comparatively higher 10.78% annualized return.

NWBO

• 1D: -0.83%
• 1M: -18.51%
• YTD: -16.85%
• 6M: -23.86%
• 1Y: -26.28%
• 3Y*: -31.62%
• 5Y*: -33.92%
• 10Y*: -11.32%

GE

• 1D: 0.38%
• 1M: 17.71%
• YTD: 15.89%
• 6M: 13.27%
• 1Y: 44.61%
• 3Y*: 63.52%
• 5Y*: 40.97%
• 10Y*: 10.78%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NWBO vs. GE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NWBO Northwest Biotherapeutics, Inc.	-16.85%	-16.74%	-60.81%	-10.64%	12.07%	-54.10%	626.19%	2.19%	-14.38%	-31.05%
GE General Electric Company	15.89%	85.73%	64.83%	95.71%	-10.92%	9.69%	-2.73%	54.00%	-55.39%	-42.92%

Correlation

The correlation between NWBO and GE is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.03
Correlation (3Y) Calculated over the trailing 3-year period	-0.01
Correlation (5Y) Calculated over the trailing 5-year period	0.03
Correlation (10Y) Calculated over the trailing 10-year period	0.04
Correlation (All Time) Calculated using the full available price history since Dec 14, 2001	0.04

Fundamentals

EPS NWBO : -$0.06 GE : $8.15
PS Ratio NWBO : 297.41 GE : 7.83
Total Revenue (TTM) NWBO : $937.00K GE : $48.35B
Gross Profit (TTM) NWBO : $416.00K GE : $16.84B
EBITDA (TTM) NWBO : -$79.62M GE : $11.01B

Return for Risk

NWBO vs. GE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NWBO

NWBO Risk / Return Rank: 23
NWBO Sharpe Ratio Rank: 25
NWBO Sortino Ratio Rank: 27
NWBO Omega Ratio Rank: 27
NWBO Calmar Ratio Rank: 19
NWBO Martin Ratio Rank: 18

GE

GE Risk / Return Rank: 78
GE Sharpe Ratio Rank: 81
GE Sortino Ratio Rank: 76
GE Omega Ratio Rank: 75
GE Calmar Ratio Rank: 77
GE Martin Ratio Rank: 79

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NWBO vs. GE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Northwest Biotherapeutics, Inc. (NWBO) and General Electric Company (GE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	NWBO	GE	Difference
Sharpe ratio: Return per unit of total volatility	-0.39	1.42	-1.81
Sortino ratio: Return per unit of downside risk	-0.21	1.96	-2.17
Omega ratio: Gain probability vs. loss probability	0.98	1.25	-0.28
Calmar ratio: Return relative to maximum drawdown	-0.63	2.15	-2.78
Martin ratio: Return relative to average drawdown	-1.12	5.81	-6.92

NWBO vs. GE - Sharpe Ratio Comparison

The current NWBO Sharpe Ratio is -0.39, which is lower than the GE Sharpe Ratio of 1.42. The chart below compares the historical Sharpe Ratios of NWBO and GE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

NWBO vs. GE - Drawdown Comparison

The maximum NWBO drawdown since its inception was -99.99%, which is greater than GE's maximum drawdown of -85.53%. Use the drawdown chart below to compare losses from any high point for NWBO and GE.

Drawdown Indicators

	NWBO	GE	Difference
Max Drawdown Largest peak-to-trough decline	-99.99%	-85.53%	-14.46%
Max Drawdown (1Y) Largest decline over 1 year	-41.54%	-20.85%	-20.69%
Max Drawdown (3Y) Largest decline over 3 years	-82.16%	-21.36%	-60.80%
Max Drawdown (5Y) Largest decline over 5 years	-90.29%	-44.94%	-45.35%
Max Drawdown (10Y) Largest decline over 10 years	-91.93%	-81.18%	-10.75%
Current Drawdown Current decline from peak	-99.99%	-0.33%	-99.66%
Average Drawdown Average peak-to-trough decline	-97.15%	-25.77%	-71.38%
Ulcer Index Depth and duration of drawdowns from previous peaks	23.56%	7.70%	+15.86%

Volatility

NWBO vs. GE - Volatility Comparison

Northwest Biotherapeutics, Inc. (NWBO) has a higher volatility of 17.80% compared to General Electric Company (GE) at 9.33%. This indicates that NWBO's price experiences larger fluctuations and is considered to be riskier than GE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NWBO	GE	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.80%	9.33%	+8.47%
Volatility (6M) Calculated over the trailing 6-month period	47.20%	26.93%	+20.27%
Volatility (1Y) Calculated over the trailing 1-year period	67.36%	31.69%	+35.67%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	81.98%	31.09%	+50.89%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	92.88%	36.38%	+56.50%

Dividends

NWBO vs. GE - Dividend Comparison

NWBO has not paid dividends to shareholders, while GE's dividend yield for the trailing twelve months is around 0.43%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
GE General Electric Company	0.43%	0.47%	0.67%	0.25%	0.38%	0.34%	0.37%	4.12%	4.89%	4.81%	2.94%	2.95%
NWBO Northwest Biotherapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both NWBO and GE in my portfolio?

NWBO and GE have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NWBO or GE?

NWBO has higher volatility (17.80%) compared to GE (9.33%). In terms of maximum drawdown, NWBO dropped -99.99% vs GE's -85.53%.

Which has better risk-adjusted returns?

GE currently has the higher Sharpe Ratio (1.42 vs -0.39), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.